Senator Investment Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Senator Investment Group’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-125,000	Closed	-$13.4M	–	64
2023 Q1	$13.4M	Buy	125,000 +25,000	+25%	+$2.88M	0.73%	33
2022 Q4	$11M	Buy	+100,000	New	+$6.48M	0.99%	31

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Senator Investment Group's RXDX Position: Q2 2023 in Review

Senator Investment Group sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 125,000 shares — an estimated $13.4M sold.

Senator Investment Group first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $13.4M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Senator Investment Group reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Senator Investment Group sold 125,000 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $13.4M.
Senator Investment Group first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Senator Investment Group's Prometheus Biosciences, Inc. Common Stock position peaked at $13.4M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Senator Investment Group's 13F filing for Q2 2023, filed 11 Aug 2023.